Article
Assessing the Clinical Outcomes of Voxelotor Treatment in Patients with Sickle Cell Disease
2024-03-31
Abstract excerpt
The results of Voxelotor treatment in Sickle Cell Disease, as assessed through clinical outcomes, demonstrated its efficacy in reducing hemolysis and improving hemoglobin levels. This effect can be attributed to Voxelotor's inhibition of HbS polymerization, thereby restoring the deformability and compliance of sickle RBCs. Our mathematical model provided mechanistic insights into how altered rheological properties...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8cddd9eb-93c8-5b75-a3f9-1c1e051d3a72
- DOI
- 10.3126/ijasbt.v12i1.64057
